Background: Delusional infestation (DI) is a well-recognised delusional disorder presenting as the persisting belief in the presence of parasitic or other infestations. Combined clinics have been run by dermatology and psychiatry in a small number of centres. Here we report the first few years of a unique combined clinic run with experts in infectious diseases/tropical medicine and psychiatric management of DI.
Introduction
Delusional infestation (DI, previously known as delusional parasitosis or Ekbom's syndrome) usually causes considerable difficultly for patients and has been recognised by clinicians for more than 100 y. [1] [2] [3] The condition presents as a fixed belief that the patient's skin, body or environment is infested by living or inanimate pathogens, with no medical evidence of this. Primary cases of DI meet the criteria for persistent delusional disorder within the International Classification of Diseases, 10th Revision (ICD-10; F22.0). Secondary cases related to substance misuse, prescribed drugs (such as dopaminergic agents) and medical and psychiatric diagnosis are also well recognised. 3 Research into the underlying mechanism for DI suggests dysfunction within the regions of the brain responsible for judgement, sensation and learning, supporting the hypothesis that these delusional beliefs are due to misinterpretations of peripheral signals that result in favouring an unlikely explanation of these sensations (errors of probabilistic reasoning). 4 Antipsychotic medication has been shown to improve symptoms in DI, [5] [6] [7] however, engaging patients can be challenging, resulting in high rates of non-adherence to recommended medication. 8, 9 Combined clinical services with dermatology or other medical services have been proposed as the optimal way to manage patients with DI, allowing them to engage with psychiatric services. 10 There is increasing evidence that this approach is likely to be cost effective in reducing the overall number of investigations and repeat referrals that can occur in DI. 11 Much less common is a combined clinical service run in conjunction with infectious disease or tropical medicine specialists.
Currently we are aware of such clinics in only Liverpool and Berlin. However, the Berlin clinic only has access to psychiatric expertise rather than being a truly jointly run clinic. UK residents are travelling abroad more frequently 12 with increased exposure risks for unusual infections and infestations. Travel has previously been described as a possible trigger for DI, 13, 14 as well as reports of cultural variations in the presentation of DI in different parts of the globe. [15] [16] [17] [18] There have also been reports of DI where an individual may have been exposed to a parasitic infection, such as entomologists or animal owners presenting to vets with alleged symptoms of infestation in their pets. [19] [20] [21] This article discusses the experience of a combined psychiatry and tropical medicine clinic for DI, the prevalence of illnesses in the patients assessed, outcomes, the approach used in the clinic and review of a clinical database of cases.
Methods
A combined psychiatry and tropical medicine clinic has been running twice per month since 2011 at the Liverpool School of Tropical Medicine. Referrals are accepted from within the Merseyside and North Wales regions as well of out-of-area referrals. Referrals are accepted from primary and secondary care and are screened by consultants from both disciplines for suitability ( Figure 1 ). The aim of this screening process is to identify those patients felt most likely to have DI rather than requiring assessment at the general tropical medicine clinic. Criteria identified in referral letters that led to prioritisation for assessment in the DI clinic include a history suggestive of DI (a persistent, strong belief of being infested in combination with unusual constellations of symptoms), a previous diagnosis of DI made by a colleague and the duration and degree of distress associated with the symptoms. Prior to attending the clinic, patients are asked to have basic routine blood tests (full blood count, urea and electrolytes, liver function test) and an electrocardiogram. This is to help with the exclusion of real infestations (high eosinophil count) and provides a baseline QTc interval in case antipsychotics are suggested. Each clinic session is booked for 1 hour and an introduction of all team members and the aims of the clinic is performed at the beginning of each clinic. The psychiatrist is introduced as an integral part of the clinic, as symptoms such as those experienced by the patient often cause significant distress and can be associated with psychiatric morbidity. The initial clinic appointment is led by the tropical medicine consultant, taking a classic medical history and performing an examination. Important parts of the history include any travel history or other activities that could expose an individual to unusual infections or infestations. Examination includes a close examination of areas of concern for the patient and perceived areas of skin change or infestation. Investigations are limited to those tests which the tropical medicine consultant feels are appropriate given the history and examination. Any specimens brought by the patient are reviewed in the diagnostic parasitology laboratory. It is pointed out that this is a specialist laboratory able to identify most known parasites by microscopy. Patients are encouraged to provide specimens for examination, because it helps with any later explanations of the assessment. Where appropriate, a diagnosis of primary DI (persistent delusional disorder within ICD-10; F22.0), or of DI in the context of another illness (secondary DI) 10 is made. In accordance with ICD-10 F22.0, a diagnosis of primary DI is made in the presence of a persistent stable delusional belief of being infested as the main clinical feature in the absence of schizophrenic symptoms, marked blunted affect or evidence of organic brain disease. In the presence of other organic, psychiatric or neurological disorders, a diagnosis of secondary DI is made. Alternative diagnoses were made according to standard diagnostic criteria; of note, the diagnosis of 'health anxiety' was made with reference to ICD-10 F45.2, hypochondriacal disorder.
At this stage the tropical medicine consultant determines whether the presentation is likely due to infestation or not and the rationale behind the decision. It is pointed out that the patient's symptoms are believed and that the clinician's intention is to identify the cause of the symptoms with an open mind. If DI is felt to be a likely diagnosis, the clinician explains three possible options, with the aim of introducing the possibility of a non-parasitic explanation of the symptoms to the patient. The three explanations include a hitherto unknown infestation, an infestation that has subsided but left the patient with residual symptoms or an illness of the brain. If the feeling of the team is that this is likely to be DI, the psychiatrist may take over leading the consultation at this stage. An explanation is presented that sensations can be abnormally interpreted by the brain, and the benefit of antipsychotic medication in ameliorating these sensations is emphasised. The diagnosis is not explicitly explained as a delusional illness at an early stage unless the patient specifically asks. Follow-up sessions are structured along similar lines, with the tropical medicine consultant emphasising the lack of physical evidence of infestation and risk factors while the psychiatrist emphasizes problems with errors of probabilistic reasoning, encouraging adherence to medication.
Patients often respond with a high degree of scepticism to any explanation of symptoms that does not fit their own (of being infested). However, by building rapport and trust, it is often possible to persuade patients to try medication against their 'better judgment'. In other words, they may try the medication because they are persuaded by the possibility of an alternative explanation, because they trust the doctors to have their best interest at heart or because they feel they have nothing to lose by trying. Occasionally they become dismissive, and it requires skill to keep them on board, which is possible in most cases. The degree to which patients are able to consider an alternative explanation usually corresponds with the degree of their delusional intensity.
A clinical database was collected prospectively focusing on initial assessment, duration and severity of symptoms, clinical diagnosis made during assessment and follow-up appointments. Additional information on clinical presentation and previous investigations was retrospectively collected from clinical notes and clinic letters and added to the database. Descriptive statistics were used. The nature of the clinic meant that formalised statistical analysis was not carried out. Data were presented according to the final clinical diagnosis and categorised as all DI (primary and secondary combined) and non-DI patients. Outcome data are collected with the Clinical Global Impressions Severity (CGI-S) scale, 22 which is routinely generated for most patients. CGI-S scores are clinician rated, well validated, have high interrater reliability and take a holistic approach to the patient's Transactions of the Royal Society of Tropical Medicine and Hygiene overall level of impairment. A score of 1 means 'no illness' while the highest score of 7 means 'one of the worst cases seen'.
Results

Seventy-five patients attended for assessment between 19
December 2011 and 31 October 2016 (Table 1) . Approximately two-thirds of clinic attendees were diagnosed with DI (n=52/ 75), two of whom had a shared delusional belief. This shows a reasonably successful screening process. No patient objected to the presence of the psychiatrist. Five patients had secondary DI, with illicit drug use (cannabis, amphetamines and cocaine), schizoaffective disorder, depression and dopaminergic Parkinson's drugs being the causes. Health anxiety was the most common diagnosis seen in those not considered to have DI (n=8/23). All patients with health anxiety fulfilled general ICD-10 criteria for F45.2 (hypochondriacal disorder, sometimes known as illness anxiety disorder), but some focussed their anxieties on overvalued ideas about infestations. Other causes 
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included irritable bowel syndrome (2), depression (2), no illness identified (2), anxiety (2), depression and anxiety (1), chronic fatigue syndrome (1), gut motility disorder (1), impetigo (1), idiopathic pruritus ani (1) and diagnostic uncertainty (2) . Psychiatric diagnoses were made using ICD-10 criteria; some patients came with diagnoses made by external clinicians, which we confirmed. Reported symptoms were very similar between DI and non-DI patients. Abnormal sensations were common in non-DI patients but were almost universally seen in DI (Table 2) . Most patients had been investigated previously and had often seen multiple specialties as well as attending private clinics and private (unregulated) laboratories. Previous treatment for parasitic infestation was common, often initially by general practitioners, and then procured from alternative sources by patients. Multiple courses of anti-helminthic or anti-parasitic agents had often been taken. Symptoms had often been present for many years (up to 20 y in some cases). Patients commonly reported medical comorbidities, but this was seen more frequently in those not diagnosed with DI. A previous psychiatric diagnosis was present in approximately 40% of patients of both groups.
Patients were investigated in accordance with the agreed approach in the clinic. Only tests the tropical medicine physician felt were appropriate were done. However, all specimens brought to the clinic were reviewed. Providing a specimen at the first clinic appointment was more common in those with DI (39% [20/52] Patient outcome was variable. Loss to follow-up and erratic attendance at follow-up clinic appointments was common (Table 3) . A few patients requested discharge from the clinic as they did not agree with the diagnosis of DI or the treatment approach. Of the patients diagnosed with DI, 77% were offered antipsychotics at some time during their clinic attendance, but only 28% of these reported good adherence to treatment. Interestingly, patients who reported good or partial adherence to antipsychotics had a longer average duration of symptoms (67. 8 
Discussion
Joint or combined clinics between psychiatry and either dermatology or tropical medicine have been proposed as a way forward in the treatment of DI, although few such clinics exist. The overall success rate in our combined clinic was good, with 61% of those who were not lost to follow-up reporting improvement. Unsurprisingly, those with good adherence improved much more (an almost 2 point CGI-S reduction) than those with poor adherence, who showed little improvement. Of all patients seen, 31% were not diagnosed with DI, which seems acceptable for a clinic that sees patients with a complex infestation symptom history. Equally, it suggests that the clinicians keep an open 10 (19) 2 (9) PMH: past medical history. Transactions of the Royal Society of Tropical Medicine and Hygiene mind with regards to the diagnosis, which is an important aspect of the clinic's approach. No infestations were identified, suggesting an excellent screening process with regard to identifying patients without actual current infestations. Of our DI patients, 40% had a past psychiatric history, which is similar to research done at a psycho-dermatology clinic in London where DI patients are seen. 23 With regards to the alleged pathogens and symptoms, we had a high number of alleged worms compared with previous studies (31% in our sample compared with 6% in a previous sample). 24 In a previous study, 25 it was the combined clinic in Berlin, also run by a school of tropical medicine, that had the most alleged worms in their sample. In comparison, all combined clinics run with dermatologists had few patients complaining of alleged worms. This indicates there are differences among combined clinics, with clinics run by dermatologists having a different focus of patient complaints, as skin complaints rather than systemic infestations seem to be the main presenting problem. These differences are confirmed by our finding that almost all of our patients complained about abnormal sensations, whereas few have primary skin complaints. We also know from further analysis of our group's data that despite this difference, the baseline CGI-S scores appear to be very similar in all specialist clinic settings. 26 This shows that the overall impairment of patients because of the illness is similar in all settings despite a different patient mix. It is unclear at this point whether specific presentations of DI may be more difficult to treat than others. Anecdotally, we believe that patients who present with systemic rather than defined skin symptoms may be more difficult to treat, because it is more difficult to discuss a diagnosis them with unspecific terms such as 'unexplained dermopathy', and it is rarely possible to give them dermatological treatment to facilitate engagement in the treatment process.
In our patients, those with a diagnosis of DI were significantly more impaired at baseline compared with those without a DI diagnosis. Otherwise, the two samples were remarkably similar. The only other significant difference was the lack of illicit drug use in the non-DI group compared with the DI group. These findings do not suggest any specific indicators that can differentiate DI and non-DI patients a priori to aid the screening process.
Recent research has shown that the longer DI remains untreated, the worse the prognosis, 26 increasing pressure to intervene early with DI patients. This increases the need for specialist settings, as treatment rejection is high in routine primary care or dermatology settings. 3 It also highlights the need for early referral and treatment to optimise outcomes. In combined clinics with dermatology and psychiatry, the cost-effectiveness of such clinics has already been shown compared with standard treatment prior to referral to a combined clinic. Altaf et al. 11 showed a 42% reduction in overall treatment costs, indicating that psychodermatology clinics are a cost-effective service for managing patients with DI. We have not formally evaluated the cost-effectiveness of our clinic, but it is likely that any effective combined clinic will reduce costs.
The disadvantage of tertiary settings is that it may be difficult to link with local psychiatric or primary care services or, if the patient does not improve, there may be no backup system or associated community service that can take over engagement of the patient. Therefore long-term aftercare remains a problem when patients refuse to engage with local services. It begs the question whether tropical medicine/infectious diseases services along with dermatology should be up-skilled to deal with DI patients more effectively without the need for rare tertiary services, to widen the options for patients and improve referral to treatment times. Given the complexity of some of the psychiatric aspects of the illness (risk, antipsychotic treatment, possible use of mental health legislation), close links with local psychiatric services should promote the safety and feasibility of such an up-skilling process.
Conclusions
Combined clinics for DI between tropical medicine/infectious diseases and psychiatry services are effective in delivering improved outcomes. The patients' symptom focus differs somewhat from those presenting to dermatology, which presents additional challenges. Early treatment remains important. The lack of combined clinics makes the up-skilling of infectious disease/tropical medicine clinicians in DI desirable.
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